AU2001232243A1 - Nerve growth factor activity potentiating agents - Google Patents

Nerve growth factor activity potentiating agents

Info

Publication number
AU2001232243A1
AU2001232243A1 AU2001232243A AU3224301A AU2001232243A1 AU 2001232243 A1 AU2001232243 A1 AU 2001232243A1 AU 2001232243 A AU2001232243 A AU 2001232243A AU 3224301 A AU3224301 A AU 3224301A AU 2001232243 A1 AU2001232243 A1 AU 2001232243A1
Authority
AU
Australia
Prior art keywords
growth factor
nerve growth
factor activity
potentiating agents
activity potentiating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232243A
Inventor
Hidenao Fukushima
Toshio Itoyama
Yuto Kamei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of AU2001232243A1 publication Critical patent/AU2001232243A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
AU2001232243A 2000-02-08 2001-02-08 Nerve growth factor activity potentiating agents Abandoned AU2001232243A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000030546 2000-02-08
JP2000-30546 2000-02-08
PCT/JP2001/000878 WO2001058437A1 (en) 2000-02-08 2001-02-08 Nerve growth factor activity potentiating agents

Publications (1)

Publication Number Publication Date
AU2001232243A1 true AU2001232243A1 (en) 2001-08-20

Family

ID=18555541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232243A Abandoned AU2001232243A1 (en) 2000-02-08 2001-02-08 Nerve growth factor activity potentiating agents

Country Status (4)

Country Link
US (2) US20030068330A1 (en)
EP (1) EP1293200A4 (en)
AU (1) AU2001232243A1 (en)
WO (1) WO2001058437A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632531B2 (en) * 2003-04-11 2009-12-15 International Flavors & Fragnances Inc. Alkyldienamides exhibiting taste and sensory effect in flavor compositions
US7361376B2 (en) * 2003-04-11 2008-04-22 International Flavors & Fragrances Inc. Alkyldienamides exhibiting taste and sensory effect in flavor compositions
EP1496042B1 (en) 2003-07-10 2009-11-11 INTERNATIONAL FLAVORS & FRAGRANCES INC. E2, E4,Z8-Undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
US7141686B2 (en) 2003-07-10 2006-11-28 International Flavors & Fragrances Inc. E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
US8007839B2 (en) * 2003-10-03 2011-08-30 International Flavors & Fragrances Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
JP2012158527A (en) * 2011-01-31 2012-08-23 Mitsubishi Gas Chemical Co Inc Prophylaxis of depression
JP5950656B2 (en) * 2012-04-02 2016-07-13 株式会社マルハチ村松 NF-κB inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02290826A (en) * 1989-04-28 1990-11-30 Sankyo Co Ltd Prenylquinone and hydroquinone derivative
JPH08768B2 (en) * 1989-08-24 1996-01-10 武田薬品工業株式会社 Nerve growth factor secretion inducer
JPH0763823B2 (en) * 1990-04-27 1995-07-12 小池酸素工業株式会社 Continuous casting cutting equipment
JPH0449259A (en) * 1990-06-14 1992-02-18 Kao Corp Novel toluquinone compound

Also Published As

Publication number Publication date
WO2001058437A1 (en) 2001-08-16
US20050192343A1 (en) 2005-09-01
EP1293200A1 (en) 2003-03-19
US20030068330A1 (en) 2003-04-10
EP1293200A4 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
AU2492000A (en) Implantable neuro-stimulator
AU3569800A (en) Pyrimidine compounds with pharmaceutical activity
AU4368100A (en) Proning bed
AU2905200A (en) Toothbrush
HUP0402171A3 (en) Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
AU2002215772A1 (en) Implantable neurostimulator
AU3736200A (en) Toothbrush
AU2002302544A1 (en) Active ingredient combinations for hair-dyeing agents
AU4402900A (en) Toothbrush
AU5493400A (en) Absorbent airlaid structure
AU2002222240A1 (en) Nerve regeneration
AU1557901A (en) Chair
AU2913800A (en) Toothbrush
AU2292301A (en) Human kinases
AU5913700A (en) Electrode design and stimulator for antler-bearing animals
AU1277101A (en) Toothbrush
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU2451500A (en) Therapeutic agents
AU2001232243A1 (en) Nerve growth factor activity potentiating agents
AU2001270129A1 (en) Human phosphodiesterases
AU5973600A (en) Therapeutic agents
AU4456800A (en) Human hac3
AU2003225401A1 (en) Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity
AU2001288238A1 (en) Methods of modulating activity of dxr
AU6150200A (en) Therapeutic agents